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Abstract
Normal tissue responses to ionizing radiation have been a major subject for study since the discovery of X-rays at the
end of the 19th century. Shortly thereafter, time–dose relationships were established for some normal tissue end-
points that led to investigations into how the size of dose per fraction and the quality of radiation affected outcome.
The assessment of the radiosensitivity of bone marrow stem cells using colony-forming assays by Till and McCulloch
prompted the establishment of in situ clonogenic assays for other tissues that added to the radiobiology toolbox.
These clonogenic and functional endpoints enabled mathematical modeling to be performed that elucidated how tis-
sue structure, and in particular turnover time, impacted clinically relevant fractionated radiation schedules. More
recently, lineage tracing technology, advanced imaging and single cell sequencing have shed further light on the
behavior of cells within stem, and other, cellular compartments, both in homeostasis and after radiation damage.
The discovery of heterogeneity within the stem cell compartment and plasticity in response to injury have added
new dimensions to the consideration of radiation-induced tissue damage. Clinically, radiobiology of the 20th century
garnered wisdom relevant to photon treatments delivered to a fairly wide field at around 2 Gy per fraction, 5 days per
week, for 5–7 weeks. Recently, the scope of radiobiology has been extended by advances in technology, imaging and
computing, as well as by the use of charged particles. These allow radiation to be delivered more precisely to tumors
while minimizing the amount of normal tissue receiving high doses. One result has been an increase in the use of
schedules with higher doses per fraction given in a shorter time frame (hypofractionation). We are unable to cover
these new technologies in detail in this review, just as we must omit low-dose stochastic effects, and many aspects
of dose, dose rate and radiation quality. We argue that structural diversity and plasticity within tissue compartments
provides a general context for discussion of most radiation responses, while acknowledging many omissions.
© 2020 The Authors. The Journal of Pathology published by JohnWiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
Within weeks of Röntgen’s discovery of X-rays in 1895
[1], many workers developed dermatitis from using low
power X-ray tubes to try to reproduce his findings. A few
years later, Becquerel showed that natural sources of
radioactivity can also cause inflammatory skin burns.
Unlike thermal burns, radiation burns develop after a
characteristic latent period, an observation that prompted
Pierre and Marie Curie to self-experiment on the dose
relationships for latency and persistence of radium-
induced lesions. The latency of inflammation in the
human skin was in fact sufficiently predictable to cali-
brate radiation tubes for clinical dosimetry using the
minimal erythematous dose as the unit. In 1905, Heineke
[2] noted that the chronology of latencies for different
tissues was relatively constant across species, even
though Miescher [3] noted several ‘waves’ of erythema
in human skin that Pohle [4] later attributed to
radiation-induced changes in capillary density. Early
histopathological observations on the vascular effects
of ionizing radiation (IR) documented swelling and
degeneration of endothelium and capillary occlusion
[5], hyperemia and exudation of serum and red cells
[6], capillary leakage [7] and inhibition of vascular cap-
illary budding [8]. A lengthy debate began as to the
importance of vascular radiation damage for loss of tis-
sue function that continues to this day [9]. Although vas-
cular responses are clearly relevant, in general the
radiation response of different adult tissues is best
explained by their diversity of structure and endogenous
stem/progenitor cell content, which are the major thrust
of this review.
Heineke [10] was the first to point to tissue differences
in time–dose responses, contrasting the very rapid
appearance of radiation-induced lymphopenia with the
2-week latency of severe dermatitis, and with the relative
lack of changes in liver and kidney over the same time
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period. He also noted that lymphocytes died within a few
hours and were cleared by phagocytes that appeared in
tissues in large numbers [11]. Differences in radiosensi-
tivity between cell populations within a tissue were
highlighted by Regaud and Blanc’s [12] detailed histo-
logical descriptions of spermatogenesis. Bergonie and
Tribondeau [13] condensed findings at that time into a
‘law’, saying essentially that ‘the effects of irradiation
on cells are more intense the greater their reproductive
activity’ [14]. This holds some truth, but there are many
exceptions, not the least being that some non-dividing
cells, such as small lymphocytes, are very radiosensitive,
dying by apoptosis. Regaud and Nogier [15] went on to
show that three radiation doses given 15 days apart
could sterilize rams without damaging the scrotum, indi-
cating that differences in proliferative potential between
tissues could be exploited by dose fractionation. This has
remained a central thesis of cancer radiation therapy
(RT) until recent times, with 1.8–2 Gy per fraction given
daily, 5 days a week for 5–7 weeks becoming ‘conven-
tional’ treatment.
The optimization of RT for cancer clearly needed to
be understood to determine how best to manipulate the
time, dose and size of dose per fraction to exploit differ-
ences between individual normal tissues and tumors.
This was aided by the advent of in vitro clonogenic
assays [16] and in vivo colony-forming assays developed
by Till and McCulloch [17]. Considered to be the
‘fathers of stem cell science’, Till and McCulloch
showed that bone marrow cell transfer in mice could pre-
vent lethality after whole body irradiation (WBI) and
that the radiosensitivity of the stem cells could be
assessed in vivo by their ability to form colony-forming
units in the spleen (CFU-S) after transfer. Withers
extended the stem cell approach by developing in situ
clonogenic assays for radiation responses in skin [18],
jejunum [19], colon [20], testes [21] and kidney [22],
whereas Jirtle et al [23] used an in vivo transfer system
to quantify radiation responses of hepatocytes. Func-
tional assays were developed for other tissues, including
lung (pneumonitis and fibrosis), spinal cord (paralysis),
wound healing (breaking strength), mucosa (inflamma-
tion) and hair follicles (epilation). Withers and
coworkers [24] developed an isoeffect formula that
became the most popular way to compare these clono-
genic and functional endpoints in different tissues based
on simple linear (α) and quadratic (β) components. By
plotting isoeffect curves for fractions of different sizes,
they showed that endpoints for late responding normal
tissues changed more dramatically with size of dose
per fraction than those for acute tissues (up to 6 weeks
after RT); a difference that could be described by α/β
ratios [25]. Withers [26] also summarized the biology
behind dose fractionation effects by the 4Rs. (1) Repair
of sublethal damage that spares late responding tissues
with slow turnover, e.g. CNS. (2) Redistribution into
the radiosensitive G2/M phase of the cell cycle that
spares tissues with slow turnover. (3) Repopulation/
regeneration that spares normal tissues with rapid turn-
over that can proliferate during a fractionated course,
e.g. mucosa. (4) Reoxygenation that decreases the hyp-
oxic radioresistant fraction within tumors. These princi-
ples have guided clinical radiation oncologists for
decades and prompted successful clinical trials for frac-
tionation schemes that deviated from the classical 2 Gy
per fraction [27].
This review will focus on how structural diversity
between adult tissues impacts their radiation responses
and how plasticity within tissue compartments might
impact their regeneration. We are not able to consider,
in full, important issues like dose, dose rate and the qual-
ity of radiation, or non-adult tissues. Low-dose stochas-
tic effects will be sacrificed for cover of deterministic
effects. Much of the relevant radiobiology is derived
from animal models using photon irradiation delivered
to fairly large fields, but we will briefly comment on
how new technologies entering the clinic for cancer RT
might change existing paradigms.
Tissue diversity and response
Tissues vary greatly in both their tolerance to radiation
and in their latency, which is determined largely by the
tissue turnover. For example, in C3H mice, 14 Gy X-
rays deplete epithelium in about 3 days in the jejunum,
5 days in the colon, 10 days in the stomach,
12–24 days in the skin, 30 days in seminiferous tubules
of the testis and 300 days in kidney tubules [22]. Stem
cells have also been reported to turnover at very different
rates in different tissues under steady-state conditions
[28]. Under homeostatic conditions, by definition, the
rate of cell production equals the rate of cell loss,
i.e. the cell loss factor (ϕ) = 1.0. Asymmetric division
to give cell loss may be a property of individual ‘stem’
cells or of a population that stochastically produces on
average 50% ‘stem’ and 50% differentiating cells
[28,29]; properties that may be autonomous or mediated
through a supportive ‘niche’, a concept first defined in
1978 [30]. Regeneration occurs after cell loss and
requires an increase in cell production and a decrease
in ϕ to <1.0.
The advent of lineage tracing technology, advanced
imaging and single cell sequencing has improved the
accuracy with which the behavior of stem, and other, cel-
lular compartments in tissues can be studied. These are
reviewed elegantly elsewhere [28]. The consensus is that
there is a ‘continuum of stemness’ with considerable
steady-state heterogeneity in numbers and organization,
as well as ‘plasticity’, which includes reprogramming of
more differentiated cells towards stemness and that
could be particularly relevant in radiation-induced
regeneration [31,32]. Given this heterogeneity, we will
use the term ‘stem’ cell loosely, rather than attempt to
define it with respect to specific markers, which may
be misleading [28]. The basic cellular elements present
in most normal tissues, and the effects of IR, are summa-
rized in Figure 1. In a sense, these recent findings of stem
cell heterogeneity strengthen the relevance of in situ
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clonogenic assays as measures of radiation response, as
the term ‘clonogen’ can be taken to represent a func-
tional regenerative unit that implies stem cell involve-
ment but without prejudice.
In addition to the variables noted above, differences
between tissues with respect to radiosensitivity and vol-
ume effects may also be explained by their organization
into functional subunits (FSU), where a FSU is the vol-
ume that can be regenerated from one surviving clono-
gen [33]. For example, epilation may occur after a
lower radiation dose than desquamation simply because
hair follicles have a smaller number of clonogens/FSU
[34]. A FSU may correspond to a structural element,
for example a tubule, or may not, for example, it may
depend on how far a clone can migrate. If FSUs are
arranged in series, like links in a chain, as in the spinal
cord or nerves, tissues will probably demonstrate a
strong, high dose–volume effect over a short distance.
If arranged in parallel, as in skin and liver, the tissue will
be better able to tolerate high doses to small volumes but
may be susceptible to low doses to large volumes as
function will be determined largely by the volume not
irradiated. Tissue tolerance to IR is therefore a function
of both the number and the radiosensitivity of clonogens
in a FSU, and the number and organization of FSUs in a
tissue. This analysis requires that normal tissues have
stem cells or clonogenic regenerating units, which will
now be discussed with respect to tissue turnover.
Acute responding tissues
Acute responding tissues, like intestine, bone marrow,
skin and testes, turn over rapidly and have well-defined
stem cell populations, at least a portion of which actively
cycle under steady-state conditions. However, responses
of these tissues to IR vary considerably, as does their
ability to regenerate. Regeneration can be measured by
split-dose experiments, i.e. the size of a second dose
needed to negate the effect of prolongation in overall
treatment time. In such experiments, the jejunum
recovers rapidly andwell, with the replicating pool being
regenerated prior to differentiation being resumed; ϕ
becomes close to zero. For skin, ϕ becomes closer to
0.5, whereas regeneration in the testes is very slow and
ϕ is little altered. Sperm counts remain low for a long
time after exposure. These differences are relevant to
the fractionation schedule used clinically and to the
retreatment of lesions with RT, but also mean that each
tissue must be considered on its merits.
The jejunum turns over very rapidly. The crypt houses
a niche where basal columnar epithelial stem cells (BSC)
reside. At least some BSCs cycle daily and give rise to
rapidly proliferating progenitor/transit amplifying cells
that differentiate into mature intestinal epithelial cells
that journey up the villus and are shed into the lumen
[35]. BSCs that express the R-spondin receptor and
Wnt target molecule LGR5 are interspersed between
Paneth cells, which, together with crypt structure, mes-
enchymal fibroblasts, endothelium, pericytes and other
cell types, nurture and protect the stem cell population
by providing Notch, WNT and BMP family members,
growth factors such as EGF and cytokines such as IL-
11 and IL-22 [36].
After 19 Gy total abdominal irradiation, which is
lethal for 50% of defined-flora C3H mice by
5–10 days, jejunal clonogenic cell survival is decreased
Figure 1. Some of the features defining most normal tissue radiation responses. A general outline of the turnover of cell populations in nor-
mal tissues is presented in the upper panel. In the lower panel, IR triggers damage responses that set in motion recurring cascades of oxida-
tive/reductive forces that aim to restore function but instead cause further cell death, senescence and autophagy, and immune involvement
in the form of a myeloid shift and chronic inflammation.
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to about 8 × 10–6 [37]. The colon is generally more
radioresistant and responds later than the small intestine
[20,38]. Radiosensitivity varies with the strain of mouse,
the length along the intestine, the proximity of Peyer’s
patches [39] and the microbial flora, as irradiation can
promote bacterial translocation across the intestinal bar-
rier [40]. Furthermore, intestinal acute radiation syn-
drome (iARS) after WBI requires a lower dose than
after total abdominal irradiation, a difference that can
be neutralized by transfer of immunohematopoietic
cells, suggesting ‘accelerated’ hematopoietic ARS as a
potential cause of death [37,41]. The LGR5+ BSCs have
been reported variably as radiosensitive [42] and radio-
resistant [43], but they are generally depleted from the
crypt by 3.5 days after 14 Gy and clonogenic epithelial
foci begin to appear from a radioresistant subset. In
1977, Potten [44] suggested that these reside at position
+4 just above the uppermost Paneth cell; a populationwe
now know to be LGR5− and Bmi1+ [42]. Mindful of the
pitfalls involved in the use of markers [45], the data sug-
gest that a Bmi1+ radioresistant reserve stem cell pool, or
at least a reprogrammable plastic population, restores
LGR5+ cells in the crypt niche as well as the radiosensi-
tive transit amplifying compartment following irradia-
tion exposure [42,46]. It should be noted that
reprogramming may be limited by p53-mediated DNA
damage responses (DDR) [47] and it is dose and time
dependent, senescence sensitive [32] and influenced by
non-targeted effects [48].
Bone marrow, under steady-state conditions, contains
primitive hematopoietic stem cells (HSC) that are func-
tionally and molecularly heterogeneous but within
which is a rare population with unique capability for
self-renewal and multilineage differentiation [49]. HSCs
are held in niches under the influence of various adjacent
stromal cells that present bound or secreted molecules,
including the classic hematopoietic CSFs, CXCL12,
pleiotropin and many other signals [50,51]. Several
niches have been proposed, but differential expression
on lineage-negative HSC of signaling lymphocytic acti-
vation molecule (SLAM) family receptors, such as
CD150, CD48 and CD244, has most clearly defined a
vascular niche with HSCs in proximity to arterioles
and sinusoids [52]. Numerous influences on HSC behav-
ior by factors derived from endothelium, pericytes and
fibroblasts have been described [51]. Indeed, there is
growing evidence for a hemangioblast stem cell that
can give rise to both HSCs and endothelial progenitor
cells [53]. At least those HSC capable of long-term line-
age reconstitution in radiation-conditioned hosts (LT-
HSC) are largely non-cycling and stay in the bone mar-
row [54], but produce low levels of progenitor cells that
are released into the circulation under normal conditions.
Egress is achieved through a complex interplay of cyto-
kines, chemokines and adhesion molecules, particularly
involving the SDF-1/CXCR4 axis, purinergic signaling
and phosphosphingolipids [50]. As HSCs differentiate
they follow a hierarchical ‘age’ structure with progres-
sive restriction in lineage and self-renewal (Figure 1),
which is reflected in the changing composition of
exogenous CFU-S on days 5, 8 and 11 after marrow
transfer into irradiated hosts [55]. There is also evidence
of a self-sustaining myeloerythroid progenitor popula-
tion [56] that acts as an emergency reserve of immature
and maturing leukocytes for rapid mobilization in
response to challenge, such as after WBI.
Radiation responses in the hematopoietic system are
inevitably complex. Circulating lymphocytes are very
radiosensitive, dying largely by apoptosis. Levels drop
rapidly, even after local irradiation as cells circulate
through the radiation field. Circulating myeloid cells by
contrast can transiently increase in number within hours
after local IR or even lethalWBI, forming part of an emer-
gency mobilization response [57]. Precursors appear in
the circulation that express both neutrophil and macro-
phage markers [58]. These migrate into many tissues,
irradiated or not, under the influence of CSF1 [59] and
perhaps CCL2, IL-6 and IFN-α/β pathways [58,60]. Later
overshoots in the production of myeloid cells in the circu-
lation have been described in many species [57]. Quies-
cent LT-HSC are relatively radioresistant, but appear to
be very sensitive to oxidative stress, which can be gener-
ated by even low (0.02 Gy) doses of IR [61], generated
directly or through proinflammatory pathways
(Figure 1). Radiation-induced senescence is a likely out-
come of radiation-induced oxidative stress, as is autop-
hagy [62,63]. Proinflammatory responses are controlled
by reductive pathways, especially those under Keap1/
Nrf2 control, that critically regulate LT-HSC levels
[61,64]. Nrf2 also regulates PU.1, the master myeloid cell
regulator [65], probably through NAD(P)H:quinone oxi-
doreductase, whose loss leads to myeloid hyperplasia
[66]. However, a common result is a long-term defect in
HSC reconstituting ability and continuing cycles of oxi-
dative and reductive stress [61,67] and inflammation,
with a myeloid shift; a pattern that is repeatedly rein-
forced [68,69]. These chronic inflammatory events are a
hallmark of late radiation effects, including life shorten-
ing [69]. G-CSF [70] and probably other inflammatory
stimuli can exacerbate the HSC defect, which raises ques-
tions as to the use of CSFs as mitigators of radiation dam-
age. These radiation-induced changes appear to be
remarkably similar to aging with its LT-HSC defects
[71], and upregulation of genes specifying the myeloid
cells at the expense of those of the lymphoid system
[72]. Perhaps a myeloid shift is the price we pay for hav-
ing a self-sustaining, partly autonomous myeloerythroid
progenitor population that responds rapidly to injury to
initiate tissue repair [56]. This population is sufficient to
protect against hematopoietic acute radiation syndrome
(hARS) in mice and is responsible for the day 8 CFU-S
population [73]. Rapid recovery of this progenitor popu-
lation may allow sufficient time for the regeneration of
other hematopoietic compartments with slower turnover.
Certainly, promoting this population results in mitigation
of hARS and other WBI syndromes [58]. Not surpris-
ingly, this is dose-dependent and after higher WBI doses
accelerated hARS can occur, which is presumably due to
critical loss of a more differentiated progenitor cell
population.
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In the skin andmucosa, squamous epithelia proliferate
solely in the basal layer and cell loss is determined
largely at the population level [28,74]. Progeny commit-
ted to differentiate migrate upwards to form a layer of
keratinocytes that are then shed. After IR exposure, cells
lost from the proliferating compartment are regenerated
by a shift towards symmetrical division and differentia-
tion decreases, although shedding continues unabated.
The extent of clonogenic cell depletion determines the
outcome. Survival of >10−6 clonogens per cm2 is needed
to prevent radiation-induced moist desquamation in
mouse skin [18]. Proliferating clones can often be seen
in skin and mucosa of patients during conventional
RT. The mucosa begins to repopulate 10–12 days after
the initiation of treatment and this increases the tolerance
of the tissue by at least 1 Gy/day, equivalent to a dou-
bling of clonogens every 2 days [18]. Other epidermal
stem cell pools exist in the skin in follicles, glands and
other sites that are competent to differentiate along all
epidermal lineages. Although, normally, their involve-
ment is restricted to their own lineage their additional
plasticity may manifest in injury situations [28].
In testes, Regaud [12] showed that radiosensitivity
decreased with differentiation, radiating from spermato-
gonia on the periphery to spermatids in the center of the
seminal tubules [16]. Spermatogenesis is very radiosen-
sitive, with transient infertility around doses above
0.1 Gy that is permanent at 5–8 Gy [75]. Spermatogenic
stem cells cycle continuously, but slowly, in the basal
layer of the tubules, appearing to divide symmetrically
before differentiating into mature haploid spermatozoa,
a process that takes about 70 days. Single cell tracing
in mice of GFRalpha1+ stem cells in vivo suggests an
additional dynamic dimension where syncytial sper-
matogonia can contribute to stem cell function in
homeostasis. After irradiation, spermatogenesis is only
partially restored and regeneration is poor [21,76].
Recovery is very slow, taking 1–2 years after 2–3 Gy,
with a risk of azoospermia after higher doses [77].
Acute radiation syndromes (ARS)
Dose–time lethality curves of iARS and hARS are fairly
predictable. iARS occurs before hARS but requires a
higher dose. Mortality occurs within a narrow dose win-
dow. Increasing the dose decreases latency slightly
before a plateau is reached [41,57]. Mortality is gener-
ally due to loss of proliferative stem/progenitor cells that
fail to provide functional cells, but other causes have
been identified. For example, immunosuppression can
allow bacterial translocation across the gut and sepsis
with lethality that is generally earlier than normal and
occurs after lower doses. Immunosuppression may
resolve in a couple of months, but full immune reconsti-
tution may take many months or years, or may never
occur. Extensive skin damage can also contribute to
morbidity and mortality. For example, about 20% of
Chernobyl patients who developedARS had skin lesions
involving over 50% of their body surface; some had
respiratory tract lesions, probably from isotope
inhalation. A small number had beta burns as the pri-
mary cause of death [78].
In addition to iARS and hARS, a cerebrovascular/
CNS syndrome (CVS/CNS-ARS) can occur within a
day or two after exposure to very high radiation doses
(e.g. >20 Gy). This is associated with edema, hemor-
rhage and neutrophil infiltrates and, although some oli-
godendrocytes die by rapid radiation-induced apoptosis
[79], vascular damage is the most likely culprit, which
may be through direct cell kill or radiation-induced
TNF-α or VEGF [80].
A detailed description of radiation-induced inflamma-
tion [81] is beyond the scope of this review, but is rele-
vant to radiation-induced tissue damage (Figure 1). In
brief, although the initial wave of ROS generated by IR
through radiolysis of water is over within 10−3 s, ROS
levels remain high, being generated by biological pro-
cesses; the main sources being damaged mitochondria
and activated NADPH oxidases (NOX/DUOX). Classic
ATM-p53-bax DDR cause ROS release from mitochon-
dria. Immune DDR involves damage-associated molec-
ular pattern (DAMP) molecules released from damaged
cells, like HMGB1 [60], and cytoplasmic RNA and
DNA [82]. Toll-like receptors, RIG-1 (RNA) and
cGAS/cGMP/STING (DNA) sensors connect DDR to
proinflammatory responses, largely through NF-κB and
TKB1/IRF3 pathways, to activate positive and negative
feedback loops for senescence, autophagy and cell death
that perpetuate redox imbalances [60,83,84]. Oxidative
and reductive forces drive polar opposite phenotypes in
the immune system and dictate the nature of the cyto-
kines expressed and their role in normal tissue endpoints
[85], including fibrosis [86]. One consequence is the
establishment of self-sustaining periodic redox alter-
ations and persisting cycles of tissue damage and inflam-
mation. Radiation-induced micronuclei are major
sources of cytoplasmic DNA and activate the cGAS/
cGMP/STING pathway. As these are produced during
mitosis, they link the production of proinflammatory
cytokines, especially type 1 IFN, to cell turnover. Fur-
thermore, late effects in general are characterized by
the presence of increasing chronic inflammatory
responses that cause considerable morbidity, frailty and
life shortening.
Late responding tissues
The fairly distinct, if plastic, stem, progenitor, functional
cell compartments with rapid turnover and acute
responses to IR seen in hierarchical tissues [87] can be
contrasted with late responding tissues with slow turn-
over, where it has been less easy to identify the contribu-
tion of stem cells to homeostasis and radiation-induced
regeneration. This distinction is important, as dose frac-
tionation in the clinic spares slowly responding tissues
more than those that show an early response.
With the exception of CNS-ARS, the CNS is the clas-
sic late responding tissue. In adult brain, neural stem/
progenitor cells have been identified in niches in the sub-
ventricular zone and in the dentate gyrus of the
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hippocampus. These are active sites of neurogenesis.
Lineage tracing has shown that most stem/progenitor
cells cycle and turnover slowly but can be activated to
proliferate before migrating away to produce neurons
or glia [88].
After adult brain irradiation with the equivalent of sin-
gle doses of ~15–25 Gy, symptoms can appear in one or
more phases; in days to weeks (acute phase),
1–6 months (subacute phase) or around 6 months or more
(late phase). Acute and subacute symptoms are normally
reversible, but late damage is progressive and more seri-
ous. Late effects have a predilection for white matter
[89] but the histopathologic picture varies, including
coagulation necrosis, vascular fibrinoid necrosis, edema
and severe demyelination. Neurogenesis and proliferation
in the hippocampus are inhibited by even low doses of IR
[90]. Progenitor cells seem more sensitive than quiescent
stem cells and long-term repopulation and recovery are
slow [91–93]. Even though transit amplifying cells have
been reported to regenerate low-dose irradiated (4 Gy)
niches, suggesting some reprogramming can occur [88],
the role of stem cells in recovery of the CNS is still contro-
versial. The possible effects of irradiating the stem cell
niches in patients with glioma have generated consider-
able discussion, with the possibility of generating neuro-
cognitive defects being placed against the chances of the
niche being the source of glioma stem cells, suggesting
that increased radiation dose to the subventricular zone
may be associated with longer progression-free survival.
From the beginning, opinions have been divided between
glial and vascular origins of brain late effects. In general,
higher doses tend to precipitate hemorrhagic necrosis that
appears slightly earlier and at higher doses than severe
neuronal loss following demyelination [94]. Changes in
cognition, including spatial and object recognition mem-
ory, fear conditioning and pattern separation behaviors
have been ascribed to radiation-induced defects in neuro-
genesis [91,95] but, although important, these can be
detected earlier and after lower doses than late demyelin-
ation, suggesting that they can be caused by neuroinflam-
mation and oxidative stress. Proinflammatory cytokine
expression occurs in mouse brain within minutes of cra-
nial irradiation and thereafter pursues a rollercoaster path
with further increases during the subacute and late periods
that are associated with diffuse and severe demyelination,
respectively, attempts at remyelination, and gliosis with
immune cell infiltration and microglial activation
[96,97]. TNFR2 is required for proliferation of neural pro-
genitor cells [98] and its loss increases seizures in the
brain [99], including after irradiation where subacute
lethality is precipitated [80]. Therefore, although there is
evidence that radiation-induced damage to the stem cell
hippocampal niche can result in cognitive damage, its
contribution to high-dose late effects remain indirect.
The effects of irradiation on the kidney are most often
measured functionally using filtration assays and indi-
cate little recovery; previous irradiation can seriously
compromise retreatment [100]. Indeed, it remains con-
troversial whether stem/progenitor cells actually exist
in the mammalian adult kidney [101], but Withers and
colleagues [22] showed that extensive tubular damage
was the dominant lesion after irradiation, preceding glo-
merular sclerosis. Removing irradiated kidneys at 60-68
weeks after exposure he found regenerating epithelia-
lized tubules 60-68 weeks after irradiation, the number
declining logarithmically with dose.
Like the kidney, the liver has low turnover but can be
stimulated to regenerate rapidly after surgery, leading to
the general assumption that all mature hepatocytes are
able to maintain homeostasis. However, lineage tracing
in mice usingWnt-responsive Axin2 identified a popula-
tion of proliferating and self-renewing diploid cells adja-
cent to the central vein in the liver lobule that could give
rise to mature polyploid hepatocytes [102] and LGR5+
adult liver stem cells can be grown as organoids [103].
The origin of the liver clones that grow on transplanta-
tion to recipient mice and whose radiation characteristics
have been examined and found to be characteristic of a
late responding tissue, is not known [23,104].
Future clinical relevance
An important premise in RT over the last century is that
normal tissues (and tumors) vary in their response to
dose fractionation, with late responding tissues with
slow turnover being spared by fractionation more than
early responding tissues. Although this is generally true
for highly fractionated schedules, in recent years a vari-
ety of developments have been introduced into the radi-
ation oncology clinic that aim to limit the amount of
normal tissue within the radiation field. Although this
is certainly desirable, the extent to which total tumor
dose can be increased is debatable, as supralethal doses
of radiation do not necessarily improve outcome [105].
The impact of this technology on the responses of acute
and late responding tissues and the 4Rs of dose fraction-
ation is worthy of discussion.
CT/MRI imaging and faster computers have allowed
intensity-modulated RT with multileaf collimators shap-
ing the beam to conform more closely to tumor shape
while minimizing the amount of normal tissue exposed
to high-dose RT. Dose–volume histograms are produced
that estimate the dose to different tissues. As a result, the
use of hypofractionated regimens with RT given in
one to five fractions has gained in popularity as it is more
convenient for both patients and clinicians. Isoeffective
doses for the change in size of dose per fraction can
be estimated using linear (α) quadratic (β) exponents,
although there is considerable uncertainty when extrapo-
lating to high single doses. Hypofractionation makes
sense, particularly for tumors that have a slow turnover
in sites where there is little advantage from prolonged
fractionation, e.g. prostate, and there is little to be gained
from the enhanced recovery that the use of low doses per
fraction bring late responding normal tissues. However,
as stated earlier, it should be remembered that prolifera-
tion of acute responding normal tissues increases their
radiation tolerance. Indeed, many regenerate faster than
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most tumors. As a result, shorter, more intense treat-
ments can increase acute effects by not allowing enough
time for their regeneration, even if the dose is calculated
to be isoeffective for late effects and tumor. Also, vol-
ume effects, location and the organization of normal tis-
sue FSUs become more critical when intensity-
modulated RT is used and there are many unanswered
questions in this regard. Finally, the impact of hypofrac-
tionation on dose-related inflammation and immune acti-
vation in vivo is still uncertain, even though it is known
that some patients can generate tumor immunity that
can be boosted by RT, something that has resulted in a
large number of clinical trials combining RT with
immunotherapy.
In a similar vein, charged particles, especially protons
and carbon ions, have been introduced in some centers.
Charged particles have a lower entry dose and form
Bragg peaks where most of the energy is deposited. It
is possible to spread out the Bragg peak to completely
cover tumor with rapid fall-off. The paths of charged
particles are very different from photons and their rela-
tive biological effectiveness (RBE) is higher – dose for
dose. The RBE for protons is only slightly more than
for photons but carbon ions have far higher values.
Again, dose corrections can be made for RBE, although
this varies with the tissue and along the path, for example
for protons it increases at the distal end of the Bragg
peak. These uncertainties in the magnitude and location
of high RBE radiations is a concern for late responding
more than acute responding tissues.
FLASH RT is being tested where IR is delivered at an
ultrahigh dose rate (>100 Gy/s) compared with conven-
tional RT (0.1 Gy/s). FLASH RT appears to give neu-
rocognitive benefits by decreasing oxidative stress and
neuroinflammation [106]. A full explanation has still to
be established, but it may relate to alterations in the
chemical interactions between ions and radicals in space
and time, with different species being generated.
Conclusions
Different tissues have different responses to IR. Tissues
with rapid turnover and continuously cycling stem/pro-
genitor populations respond acutely after exposure and
regenerate rapidly. Such tissues show less effect of dose
fractionation as long as regeneration is not compro-
mised. Tissues with slow turnover respond late to IR
and may have less dependence on stem/progenitor cells
for regeneration and may rely more on proliferation
and reprogramming of more mature cells. Chronic
inflammation appears to play a greater role indirectly
or directly in causing tissue failure. These differences
are important in considering clinical RT and cancer treat-
ment and may need further consideration with the rapid
expansion into the clinic of novel technologies whose
radiobiological effects are less well known. They are
also relevant to mitigation of the effects of radiological
exposure in accidents or terrorist action.
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